复方红豆杉胶囊联合调强放疗治疗老年中晚期食管癌的临床疗效分析
2015-12-23崔娟娟,江晓燕,谭程
复方红豆杉胶囊联合调强放疗治疗老年中晚期食管癌的临床疗效分析
崔娟娟,江晓燕,谭程
(南通市肿瘤医院,江苏 南通 226000)
[摘要]目的探讨复方红豆杉胶囊联合调强放疗治疗老年中晚期食管癌的临床疗效。方法60例老年中晚期食管癌患者随机分为2组,联合治疗组30例,在调强放疗的同时联合应用复方红豆杉胶囊,单纯放疗组30例仅给予单纯常规放疗,比较2组临床疗效和毒副反应。结果联合治疗组总有效率为90.00%,单纯放疗组总有效率为66.67%,差异有统计学意义(χ2=8.153,P=0.037)。2组毒副反应相似,且多为Ⅰ~Ⅱ级,经处理后均可恢复正常。结论复方红豆杉胶囊联合调强放疗治疗老年中晚期食管癌疗效好,毒副反应能耐受。
[关键词]复方红豆杉胶囊;调强放疗;中晚期食管癌;老年患者
作者简介:崔娟娟(1984-),女,住院医师,主要从事临床放疗工作。E|mail:jiangsuws@163.com
DOI:10.3969/j.issn.1673-5412.2015.04.017
[中图分类号]R735.1;R730.58
收稿日期:(2015-01-05)
Fufang Hongdoushan Capsule Combined with Intensity Modulated Radiation Therapy in the Treatment of Elderly Patients with Advanced Esophageal Cancer
Cui Juanjuan,Jiang Xiaoyan,Tan Cheng
(NantongTumorHospital,Nantong226000,China)
Abstract[]ObjectiveTo investigate the clinical effect of fufang hongdoushan capsule combined with intensity modulated radiation therapy in the treatment of elderly patients with advanced esophageal cancer.MethodsSixty elderly patients with advanced esophageal cancer were randomly divided into the combined treatment group (30 patients were treated with intensity modulated radiation therapy and fufang hongdoushan capsule) and the radiotherapy alone group (30 patients were treated with routine radiation therapy),the clinical effect and toxicities were compared between the two groups.ResultsThe total effective rates were 90.00% and 66.67% in the combined treatment group and the radiotherapy alone group,respectively (χ2=8.153,P=0.037).The toxicities in the combined treatment group were similar to those in the radiotherapy alone group,the toxicities were mild and tolerable.ConclusionFufang hongdoushan capsule combined with intensity modulated radiation therapy is effect and safe for elderly patients with advanced esophageal cancer.
[Key words]fufang hongdoushan capsule; intensity modulated radiation therapy; advanced esophageal cancer; elderly patient
食管癌是我国最常见的消化系统恶性肿瘤之一,我国每年食管癌新发病例约占全球52.8%,其发病率和死亡率分别占全部恶性肿瘤的第8位和第4位[1-2]。随着人口老龄化和医疗水平的提高,70岁以上老年食管癌患者日益增多。由于临床确诊时多数患者已处中晚期,出现肿瘤广泛浸润、远端转移,无法进行手术切除治疗,且单一的化疗或放疗疗效均欠佳[3]。同时,老年患者存在基础疾病多、脏器功能差等特点,不能耐受放化疗相结合的综合治疗,为治疗肿瘤带来较大的难度。本文采用复方红豆杉联合调强放疗治疗老年中晚期食管癌,取得了满意疗效,现报道如下。……
